Cytokine Storms: Understanding COVID-19

Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19

Ackermann, M., Verleden, S. E., Kuehnel, M., Haverich, A., Welte, T., Laenger, F., Vanstapel, A., Werlein, C., Stark, H., Tzankov, A., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2015432 · Cited by 5,613

Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia

Grupp, S. A., Kalos, M., Barrett, D., Aplenc, R., Porter, D. L., Rheingold, S. R., Teachey, D. T., Chew, A., Hauck, B., Wright, J. F., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1215134 · Cited by 3,509

IL-10: The Master Regulator of Immunity to Infection

Couper, K. N., Blount, D. G., & Riley, E. M. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.9.5771 · Cited by 2,288

Cytokine Storm in a Phase 1 Trial of the Anti-CD28 Monoclonal Antibody TGN1412

Suntharalingam, G., Perry, M. R., Ward, S., Brett, S. J., Castello-Cortes, A., Brunner, M. D., & Panoskaltsis, N. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa063842 · Cited by 2,164

Thrombosis as an intravascular effector of innate immunity

Engelmann, B., & Massberg, S. (2013) · Nature Reviews Immunology · doi:10.1038/nri3345 · Cited by 1,989

Sepsis and septic shock

Hotchkiss, R. S., Moldawer, L. L., Opal, S. M., Reinhart, K., Turnbull, I. R., & Vincent, J. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.45 · Cited by 1,795

Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans

Fox, S., Akmatbekov, A., Harbert, J. L., Li, G., Brown, J. Q., & Heide, R. S. V. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30243-5 · Cited by 1,524

Interleukin-1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation Syndrome: Reanalysis of a Prior Phase III Trial*

Shakoory, B., Carcillo, J. A., Chatham, W. W., Amdur, R. L., Zhao, H., Dinarello, C. A., Cron, R. Q., & Opal, S. M. (2016) · Critical Care Medicine · doi:10.1097/ccm.0000000000001402 · Cited by 867

Hemophagocytic Lymphohistiocytosis

Al-Samkari, H. T., & Berliner, N. (2017) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-020117-043625 · Cited by 510

Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity

Min, C.-K., Cheon, S., Ha, N., Sohn, K. M., Kim, Y., Aigerim, A., Shin, H. M., Choi, J., Inn, K., Kim, J. H., et al. (2016) · Scientific Reports · doi:10.1038/srep25359 · Cited by 364

Mechanistic insights into SARS-CoV-2 spike protein induction of the chemokine CXCL10

Ghazanfari, D., Courreges, M. C., Belinski, L., Hogrell, M. J., Lloyd, J., Bergmeier, S. C., McCall, K. D., & Goetz, D. J. (2024) · Scientific Reports · doi:10.1038/s41598-024-61906-6 · Cited by 6

A prediction model for secondary invasive fungal infection among severe SARS-CoV-2 positive patients in ICU

Su, L., Yu, T., Zhang, C., Huo, P., & Zhao, Z. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1382720 · Cited by 6

Acute lipopolysaccharide (LPS)-induced cell membrane hyperpolarization is independent of voltage gated and calcium activated potassium channels

McCubbin, S., Meade, A., Harrison, D. A., & Cooper, R. L. (2024) · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology · doi:10.1016/j.cbpc.2024.110004 · Cited by 6

Therapie schwerer COVID-19-Verläufe in der Intensivmedizin

Wiesner, O., Busch, M., & David, S. (2020) · Der Internist · doi:10.1007/s00108-020-00850-9 · Cited by 6

Identification of COVID-19 subtypes based on immunogenomic profiling

Chen, Z., Feng, Q., Zhang, T., & Wang, X. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107615 · Cited by 6

Targeting of neutrophil activation in the early phase of the disease for prevention of Coronavirus disease‐19 severity

Sendo, F., Yoshitake, H., & Araki, Y. (2022) · Microbiology and Immunology · doi:10.1111/1348-0421.12978 · Cited by 5

Immune Response to COVID-19 in India through Vaccination and Natural Infection

Sarraf, T. R., Maity, S., Ghosh, A. K., Bhattacharjee, S., Pani, A., Saha, K., Chattopadhyay, D., Ghosh, G., & Sen, M. (2022) · Fortune Journal of Health Sciences · doi:10.26502/fjhs.070 · Cited by 6

Assessment of Admission COVID-19 Associated Hyperinflammation Syndrome Score in Critically-Ill COVID-19 Patients

Yıldırım, M. S., Halaçlı, B., Yüce, D., GÜNEGÜL, Y., Ersoy, E. O., & Topeli, A. (2022) · Journal of Intensive Care Medicine · doi:10.1177/08850666221131265 · Cited by 8

Association of Alleles of Human Leukocyte Antigen Class II Genes and Severity of COVID-19 in Patients of the ‘Red Zone’ of the Endocrinology Research Center, Moscow, Russia

Troshina, E. A., Yukina, M. Y., Nuralieva, N. F., Vasilyev, E., Rebrova, O. Y., Ахматова, Р. Р., Ikonnikova, A. Y., Savvateeva, E. N., Gryadunov, D. A., Mel'nichenko, G. A., et al. (2022) · Diseases · doi:10.3390/diseases10040099 · Cited by 7

Systematic Discovery and Pathway Analyses of Metabolic Disturbance in COVID-19

Li, B., Fan, X., Cao, W., Tian, H., Wang, S., Zhang, J., Lam, S. M., Song, J., Zhang, C., Zhang, S., et al. (2021) · Infectious Diseases & Immunity · doi:10.1097/id9.0000000000000010 · Cited by 7

Hasrat transhumanisme di tengah pandemi Covid-19: sebuah upaya memahami identitas diri melalui pendekatan teologi interkultural

Baito, L. (2021) · Kurios · doi:10.30995/kur.v7i2.294 · Cited by 6

Repurposing existing drugs for the treatment ofCOVID-19/SARS-CoV-2: A review of pharmacological effects and mechanism of action

Liang, Y., Quan, X., Gu, R., Meng, Z., Gan, H. K., Wu, Z., Sun, Y., Pan, H., Han, P., Liu, S., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e35988 · Cited by 7

Human Alveolar Macrophages Detect SARS‐CoV‐2 Envelope Protein Through TLR2 and TLR4 and Secrete Cytokines in Response

Grant, C., Duffin, E., O’Connell, F., Nadarajan, P., Bergin, C. J., Keane, J., & O’Sullivan, M. P. (2025) · Immunology · doi:10.1111/imm.13922 · Cited by 5

Selective Impact of Selenium Compounds on Two Cytokine Storm Players

Sinha, I., Zhu, J., & Sinha, R. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13101455 · Cited by 5

Neutrophil-platelet ratio as a predictor of acute kidney injury in severe COVID-19

Sayan, M., Altınışık, H. B., & Sayan, O. (2024) · Medicine · doi:10.1097/md.0000000000040053 · Cited by 5

Study on the Optimization of an Extraction Process of Two Triterpenoid Saponins in the Root of Rosa laevigata Michx. and Their Protective Effect on Acute Lung Injury

Mo, J.-Y., Deng, Q., Huang, Y., Jia, X., Xie, F., Zhou, B., Gao, H., Wu, Y., & Yuan, J. (2025) · Pharmaceuticals · doi:10.3390/ph18020253 · Cited by 5

Synergistic nanozyme-macrophage hybrid system for targeted therapy of acute lung injury

Wu, J., Liu, Y., Xu, J. M., Zhang, G., Xu, Q., Deng, J., Liu, Y., Li, J., Han, H., Bu, L., et al. (2025) · Nano Research · doi:10.26599/nr.2025.94907681 · Cited by 5

Early Renal-Replacement Therapy May Reduce the All-Cause Mortality of Severe COVID-19: An Observational Cohort Study

Qian, J., Wang, M., You, H., Luo, J., Li, S., Chen, S., Chen, Y., Li, X., Wang, K., Zhang, W., et al. (2022) · Blood Purification · doi:10.1159/000524229 · Cited by 5

Inhibition of IL-6 signaling prevents serum-induced umbilical cord artery dysfunction from patients with severe COVID-19

de Almeida, C. R., de Lima, J. F., Machado, M. R., Alves, J. V., Couto, A. E. S., Campos, L. C. B., Mesquita, C. D. A., Auxiliadora‐Martins, M., Becari, C., Louzada‐Júnior, P., et al. (2023) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00154.2022 · Cited by 5

Nano-Enabled Antivirals for Overcoming Antibody Escaped Mutations Based SARS-CoV-2 Waves

Rahman, A., Roy, K. J., Deb, G. K., Ha, T., Rahman, S., Aktar, M. K., Ali, M. I., Kafi, M. A., & Choi, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713130 · Cited by 5

Vaccination Criteria Based on Factors Influencing COVID-19 Diffusion and Mortality

Spassiani, I., Gubian, L., Palù, G., & Sebastiani, G. (2020) · Vaccines · doi:10.3390/vaccines8040766 · Cited by 5

Inflammatory pathways and potential therapies for COVID-19: A mini review

Dabbish, A. M., Yonis, N., Salama, M., Essa, M. M., & Qoronfleh, M. W. (2021) · European Journal of Inflammation · doi:10.1177/20587392211002986 · Cited by 5

Absence of “Cytokine Storm” in Hospitalized COVID-19 Patients: A Retrospective Cohort Study

Ciampa, M. L., O’Hara, T. A., Joel, C. L., Gleaton, M., Tiwari, K. K., Boudreaux, D. M., & Prasad, B. M. (2021) · Infectious Disease Reports · doi:10.3390/idr13020036 · Cited by 7

The role of immunomodulatory medications in the treatment of COVID-19

Sattui, S. E., Crow, M. K., & Navarro-Millán, I. Y. (2021) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000817 · Cited by 5

TNF-a and IL-10 Serum Levels in COVID-19 Patients and their Relation to Disease Severity

TAMIM, M. D. A. S. H. H., AL-DAWY, M. D. M. M. E. T. S. A., & Selim, H. M. (2022) · The Medical Journal of Cairo University/The Medical Journal of Cairo University · doi:10.21608/mjcu.2022.264601 · Cited by 4

Pentameric C-reactive protein is a better prognostic biomarker and remains elevated for longer than monomeric CRP in hospitalized patients with COVID-19

Hopkins, F. R., Nordgren, J., Fernandez-Botrán, R., Enocsson, H., Govender, M., Svanberg, C., Svensson, L., Hagbom, M., Nilsdotter‐Augustinsson, Å., Nyström, S. N., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1259005 · Cited by 5

Outcome of Myeloma Patients with COVID-19 on Active Lenalidomide-Based Therapy: Does Lenalidomide Protect From Severe COVID-19?

Tailor, I. K., Alshehry, N. F., Zaidi, S. Z. A., Marei, M. A., Motabi, I., Alfayez, M., & Altaf, S. Y. (2020) · Hematology/Oncology and Stem Cell Therapy · doi:10.1016/j.hemonc.2020.08.002 · Cited by 5

An Update on Animal Models for Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Countermeasure Development

Zhang, L., Chen, S., Zhang, W., Yang, H., Jin, Y., & Duan, G. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.770935 · Cited by 5

Quantity of IgG response to SARS-CoV-2 spike glycoprotein predicts pulmonary recovery from COVID-19

Nairz, M., Sahanic, S., Pizzini, A., Boehm, A., Tymoszuk, P., Mitterstiller, A., von Raffay, L., Grubwieser, P., Bellmann‐Weiler, R., Koppelstätter, S., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-07489-6 · Cited by 5

COVID-19 Induces Cytokine Storm and Dysfunctional Hemostasis

Ploplis, V. A., & Charles, J. T. (2022) · Current Drug Targets · doi:10.2174/1389450124666221025102929 · Cited by 5

A potential approach toward the management of sepsis: The extracorporeal cytokine hemadsorption therapy

Yıldız, A. B., Copur, S., Tanrıöver, C., Yavuz, F., Vehbi, S., Hasbal, N. B., & Kanbay, M. (2023) · Seminars in Dialysis · doi:10.1111/sdi.13188 · Cited by 4

In vitro and in vivo pharmacodynamic activity of the new compound XC221GI in models of the viral inflammation of the respiratory tract

Stukova, M., Rydlovskaya, A., Proskurina, O., Mochalov, S., Shurygina, A., & Nebolsin, V. (2022) · Microbiology Independent Research journal · doi:10.18527/2500-2236-2022-9-1-56-70 · Cited by 4

Leukocyte surface expression of the endoplasmic reticulum chaperone GRP78 is increased in severe COVID-19.

Angeles-Floriano, T., Sanjuan-Méndez, A., Rivera-Torruco, G., Parra-Ortega, I., López-Martínez, B., Martínez-Castro, J., Marin-Santiago, S., Alcántara-Hernández, C., Martínez-Martínez, A., Márquez-González, H., et al. (2023) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiac017 · Cited by 3

Lung Injury in COVID-19 Has Pulmonary Edema as an Important Component and Treatment with Furosemide and Negative Fluid Balance (NEGBAL) Decreases Mortality

Santos, J. L. F., Zanardi, P., Alo, V., Santos, V. D., Bovone, L., Rodriguez, M., Magdaleno, F., Langhe, V. D., Villoldo, A., Souvielle, R. M., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12041542 · Cited by 4

Inducible generalized activation of hSTING-N154S expression in mice leads to lethal hypercytokinemia: a model for “cytokine storm”

Martin, G. R., Arcila, C. S., Hallihan, L. J., Scheidl-Yee, T., & Jirik, F. R. (2023) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiac019 · Cited by 3

Increased inflammatory mediators levels are associated with clinical outcomes and prolonged illness in severe COVID-19 patients

Hao, W., Liu, M., Bai, C., Liu, X., Niu, S., & Chen, X. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110762 · Cited by 4

LncRNAs expression profile in a family household cluster of COVID ‐19 patients

Iancu, I. V., Diaconu, C. C., Plesa, A., Fudulu, A., Albulescu, A., Neagu, A. I., Pitica, I. M., Dragu, L. D., Bleoţu, C., Chivu‐Economescu, M., et al. (2024) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.18226 · Cited by 4

Retrospective analysis of intracranial hemorrhages in the covid-19 pandemic

Berikol, G., Berikol, G. B., & Doğan, H. (2021) · Turkish Neurosurgery · doi:10.5137/1019-5149.jtn.33824-21.1 · Cited by 4

Potential Sedative and Therapeutic Value of Dexmedetomidine in Critical COVID-19 patients

Safari, S., Jahangirifard, A., Zali, A., Salimi, A., Bastanhagh, E., Aminnejad, R., Khoshnood, R. J., & Ommi, D. (2021) · Pharmaceutical Sciences · doi:10.34172/ps.2021.26 · Cited by 4

Accuracy of screening methods of COVID-19 in pregnancy: a cohort study

Akbar, M. I. A., Gumilar, K. E., Rahestyningtyas, E., Wardhana, M. P., Mulawardhana, P., Anas, J. Y., Ernawati, Laksana, M. A. C., & Joewono, H. T. (2021) · Minerva Obstetrics and Gynecology · doi:10.23736/s2724-606x.21.04979-4 · Cited by 4

TNF-α Levels in Respiratory Samples Are Associated with SARS-CoV-2 Infection

Pereson, M. J., Badano, M. N., Aloisi, N., Chuit, R., de Bracco, M. M. E., & Baré, P. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.01411-21 · Cited by 4

Expression Pattern of Inflammatory and Anti-Inflammatory Cytokines and Key Differential Transcription Factors in Peripheral Blood Mononuclear Cells of Iranian Coronavirus Disease 2019 Patients with Different Disease Severity

Khoshmirsafa, M., Assarehzadegan, M., Fallahpour, M., Azimi, M., Faraji, F., Riahi, T., Minaeian, S., Fassahat, D., Divsalar, F., & Abbasi, M. A. (2022) · Viral Immunology · doi:10.1089/vim.2021.0224 · Cited by 4

Decision trees for early prediction of inadequate immune response to coronavirus infections: a pilot study on COVID-19

Pisano, F., Cannas, B., Fanni, A., Pasella, M., Canetto, B., Giglio, S., Mocci, S., Chessa, L., Perra, A., & Littera, R. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1230733 · Cited by 5

Levels of soluble TNF receptors (sTNFR1 and sTNFR2) increase with clinical worsening of patients and are related to COVID-19 mortality

Aciole, M. R., Gonçales, J. P., Neves, P. A. F., Soares, C. R. P., de Oliveira, M. I., Lacerda, H. R., de Lima-Neto, R. G., Moura, L. C. R. V., de Araújo, P. S. R., & de Lorena, V. M. B. (2023) · Immunobiology · doi:10.1016/j.imbio.2023.152748 · Cited by 4

Stem Cell Secretome Modulated by Arsenicum album 30C Ameliorates Lipopolysaccharide-induced Cytokine Storm in Blood Mononuclear Cells in vitro

Aphale, P., Sanap, A. P., Sharma, D. B., Kharat, A. H., Kheur, S. M., Gawade, C., Somasundaram, I., & Bhonde, R. R. (2023) · Homeopathy · doi:10.1055/s-0043-1776039 · Cited by 5

Safety of High-Dose Vitamin C in Non-Intensive Care Hospitalized Patients with COVID-19: An Open-Label Clinical Study

Corrao, S., Raspanti, M., Agugliaro, F., Gervasi, F., Bernardo, F. D., Natoli, G., & Argano, C. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13133987 · Cited by 6

Immunity‐modulated sex disparity on COVID‐19 prognosis

Liu, D., Liu, J., Zeng, S., Wang, Y., Yuan, Y., Xu, S., Wang, S., Yu, R., Feng, X., Li, H., et al. (2020) · Clinical and Translational Medicine · doi:10.1002/ctm2.164 · Cited by 4

Can SARS-CoV-2 trigger new onset of autoimmune disease in adults? A case-based review

Putry, B. O., Khairunnisa, N., Balga, H. M., Tjang, Y. S., Thadeus, M. S., Santosa, F., & Pasiak, T. F. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e11328 · Cited by 4

Cytokine Release Syndrome in Pathogenesis and Treatment of COVID-19

Hu, T., & Cho, C. H. (2022) · Current Pharmaceutical Design · doi:10.2174/138161282822220721121211 · Cited by 4

Astroglia-mediated neuroinflammation as a putative mechanism of neurological outcomes in COVID-19? Insights from a Brazilian cohort

Segabinazi, E., Tocantins, F. R., Glaser, T., Maglio, T. G., Oliveira, N. C., Castanha, A. G., Russo, F. B., Leite, P. E. C., Brito, A., Molina, C. V., et al. (2025) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2025.101115 · Cited by 4

The experience of the combined use of Roncoleukin® and Viferon® in the treatment of patients with COVID-19

Bukhtoyarov, O. V., & Самарин, Д. М. (2021) · Terapevt (General Physician) · doi:10.33920/med-12-2102-07 · Cited by 3

Relationship between Caspase-8 and SARS-CoV-2 Variants in a Sample of Iraqi Population

Ghazzi, J. J., & Fadhil, H. Y. (2022) · The Egyptian Journal of Hospital Medicine · doi:10.21608/ejhm.2022.263575 · Cited by 3

B-Cell Responses to Sars-Cov-2 mRNA Vaccines

Kardava, L., Buckner, C. M., & Moir, S. L. (2022) · Pathogens and Immunity · doi:10.20411/pai.v7i2.550 · Cited by 3

Assessment of Interleukin-13(rs20541) Genomic Polymorphism in Patients with Acute Respiratory Distress Syndrome in Relation to COVID19 Infection.

Alajrash, A., Ali, S. H. M., Al-Bayaa, Y. J., MohammedAl-Alwany, S. H., & Al-Hijazi, A. Y. (2022) · PubMed Central · doi:10.22092/ari.2022.358616.2266 · Cited by 3

Cardiovascular Comorbidities in COVID-19: Comprehensive Analysis of Key Topics

Markovič, R., Ternar, L., Trstenjak, T., Marhl, M., & Grubelnik, V. (2024) · Interactive Journal of Medical Research · doi:10.2196/55699 · Cited by 3

Aged garlic extract major constituent S‑1‑propenyl‑l‑cysteine inhibits proinflammatory mRNA expression in bronchial epithelial IB3‑1 cells exposed to the BNT162b2 vaccine

Papi, C., Gasparello, J., Marzaro, G., Macone, A., Zurlo, M., Padua, F. D., Fino, P., Agostinelli, E., Gambari, R., & Finotti, A. (2025) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2025.12903 · Cited by 3

A systematic review of immune pathogenesis of SARS-COV-2 infection

Srikumar, S., & Perumal, S. (2021) · International Journal of Advances in Medicine · doi:10.18203/2349-3933.ijam20212411 · Cited by 3

Potential role of gut microbiota in patients with COVID-19, its relationship with lung axis, central nervous system (CNS) axis, and improvement with probiotic therapy

Alibeik, N., Pishgar, E., Bozorgmehr, R., Aghaaliakbari, F., & Rahimian, N. (2022) · Iranian Journal of Microbiology · doi:10.18502/ijm.v14i1.8794 · Cited by 3

Application of the PHENotype SIMulator for rapid identification of potential candidates in effective COVID-19 drug repurposing

Maria, N. I., Rapicavoli, R. V., Alaimo, S., Bischof, E. Y., Stasuzzo, A., Broek, J. A. C., Pulvirenti, A., Mishra, B., Duits, A. J., & Ferro, A. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e14115 · Cited by 6

Inflammation Related to Association of Low Uric Acid and Progression to Severe Disease in Patients Hospitalized for Non-Severe Coronavirus Disease 2019

Kurajoh, M., Hiura, Y., Numaguchi, R., Ihara, Y., Imai, T., Morioka, T., Emoto, M., & Nishiguchi, Y. (2023) · Biomedicines · doi:10.3390/biomedicines11030854 · Cited by 3

Role of CD27 and SAMHD1 and their genetic susceptibility to COVID-19

Al-Zahrani, M. H., Alghamdi, R. A., Tarbiah, N. I., Alkhattabi, N. A., Joharjy, H. M., & Khalifa, R. A. A. (2023) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2023.103821 · Cited by 3

The Role of Environmental Factors in the Development of Idiopathic Inflammatory Myopathies: a Narrative Review

Yamamoto, S., Yoshida, A., Gono, T., & Kuwana, M. (2023) · Current Rheumatology Reports · doi:10.1007/s11926-023-01120-x · Cited by 8

Cytokine profiling in COVID-19 patients by using ion mobility-mass spectrometry-based parallel reaction monitoring

Yan, L., Yuan, C., Zhou, R., Zhong, L., To, K. K., Liu, N., Diao, X., Xie, G., Zhao, H., Hai-jiang, W., et al. (2025) · Analytica Chimica Acta · doi:10.1016/j.aca.2025.344227 · Cited by 3

A Risk Model of Admitting Patients With Silent SARS-CoV-2 Infection to Surgery and Development of Severe Postoperative Outcomes and Death

Søreide, K., Yaqub, S., Hallet, J. I., Kvaløy, J. T., & Kleppe, T. S. (2020) · Annals of Surgery · doi:10.1097/sla.0000000000004583 · Cited by 3

A promiscuous interaction of SARS-CoV-2 with bacterial products

Carissimo, G., & Ng, L. F. P. (2020) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjaa068 · Cited by 3

COVID-19 immunologic and toxicological implication: Innate immune sensor and immune escape

Luisetto, M., Khan, F. A., Khaled, E., Hamid, G. A., Mashori, G. R., Nili, B., Fiazza, C., YesvI, R., & Latishev Yu, O. (2021) · Archives of Pharmacy and Pharmaceutical Sciences · doi:10.29328/journal.apps.1001025 · Cited by 3

Dysregulation of ion transport in the lung epithelium infected with SARS-CoV-2

Dada, L. A., Vagin, O., & Sznajder, J. I. (2021) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00170.2021 · Cited by 3

Gastrointestinal manifestations of coronavirus disease 2019

Joshi, T., Ahmed, A., & Cholankeril, G. T. (2021) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000760 · Cited by 3

Electrolyte Imbalance and COVID-19 Severity in Hospitalized Patients

Miri, M., Badriahmadi, S., Shamshirian, A., Ghalibaf, A. M., & Mozdourian, M. (2022) · Nephro-Urology Monthly · doi:10.5812/numonthly-128085 · Cited by 3

COVID-19 and the Cytokine Storm

Flowers, L. O. (2020) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2020.29.004833 · Cited by 3

Antiviral Immunity in SARS-CoV-2 Infection: From Protective to Deleterious Responses

Mihăescu, G., Chifiriuc, M. C., Vrâncianu, C. O., Constantin, M., Filip, R., Popescu, M. R., Burlibaşa, L., Nicoară, A. C., Bolocan, A., Iliescu, C., et al. (2021) · Microorganisms · doi:10.3390/microorganisms9122578 · Cited by 3

Pranlukast treatment and the use of respiratory support in infants with respiratory syncytial virus infection

Kubota, J., Takahashi, S., Suzuki, T., Ito, A., Akiyama, N., & Takahata, N. (2022) · PLoS ONE · doi:10.1371/journal.pone.0269043 · Cited by 3

Analysis of Immune Response of Chicken Primary Cells by Infection With Korean IBV StrainPreprint

Lee, R., Jung, J. S., Yeo, J.-I., Kwon, H. M., & Park, J. (2021) · Research Square · doi:10.21203/rs.3.rs-201829/v1 · Cited by 3

Pathogenesis, Symptomatology, and Transmission of SARS-CoV-2 through Analysis of Viral Genomics and Structure

Rando, H. M., MacLean, A. L., Lee, A. J., Lordan, R., Ray, S., Bansal, V., Skelly, A. N., Sell, E., Dziak, J. J., Shinholster, L., et al. (2021) · mSystems · doi:10.1128/msystems.00095-21 · Cited by 42

Discovery of drugs to treat cytokine storm-induced cardiac dysfunction using human cardiac organoidsPreprint

Mills, R. J., Humphrey, S. J., Fortuna, P. R. J., Quaife-Ryan, G. A., Mehdiabadi, N. R., Devilée, L., Voges, H. K., Reynolds, L., Krumeich, S., Mathieson, E., et al. (2020) · The Sydney eScholarship Repository (The University of Sydney) · doi:10.1101/2020.08.23.258574 · Cited by 2

NYC Metropolitan Wastewater Reveals Links between Sars-Cov-2 Amino Acid Mutations and Disease Outcomes

Archana, A., Long, C., & Chandran, K. (2023) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2023.167971 · Cited by 2

Bayesian Modeling of the Impact of HBOT on the Reduction in Cytokine Storms

Jermakow, N., Brodaczewska, K. K., Kot, J., Lubas, A., Kłos, K., & Siewiera, J. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14041180 · Cited by 2

Association of gender and main comorbidities with expression of lncRNAs and mRNAs in COVID-19 patients

Abolghasemi, H., Kheiri, H., Sedighian, H., Behzadi, E., Kachuei, R., Kheirandish, M., Arabfard, M., & Fooladi, A. A. I. (2025) · Journal of Genetic Engineering and Biotechnology · doi:10.1016/j.jgeb.2025.100650 · Cited by 2

Immune dysregulation triggered by inflammatory cytokines in patients with severe respiratory infections

Li, J., Liang, S., Li, Y., Wu, J., Li, C., Gan, J., Li, W., & Wang, C. (2026) · Respiratory Research · doi:10.1186/s12931-025-03465-6 · Cited by 5

Environmental Conditions in Early Life, Host Defenses, and Disease in Late Life

Sorci, G., & Faivre, B. (2022) · Fascinating life sciences · doi:10.1007/978-3-030-90131-8_5 · Cited by 2

Frecuencia y factores de riesgo de trombosis venosa profunda asociada a pacientes con COVID-19

Parada-Guzmán, M., Sierra-Juárez, M. Á., Olivares-Cruz, S., & Balderrama, C. A. (2022) · Revista Mexicana de Angiolog�a · doi:10.24875/rma.21000035 · Cited by 2

Complement Regulation in Immortalized Fibroblast-like Synoviocytes and Primary Human Endothelial Cells in Response to SARS-CoV-2 Nucleocapsid Protein and Pro-Inflammatory Cytokine TNFα

Franke, V., Meyer, S., Schulze-Tanzil, G. G., Braun, T., Kokozidou, M., Fischlein, T. J. M., & Silawal, S. (2022) · Life · doi:10.3390/life12101527 · Cited by 2

COVID-19 as a polymorphic inflammatory spectrum of diseases: a review with focus on the brain

Tang, S. W., Helmeste, D. M., & Leonard, B. E. (2023) · Acta Neuropsychiatrica · doi:10.1017/neu.2023.17 · Cited by 3

Treatment of COVID-19-Induced Systematic Inflammatory Response and Multiple Organ Failure Using Xuebijing

Chen, Y., Guo, J., Peng, W., Xiang, X., Wang, Y., Luo, Y., Feng, Y., Wong, V. T., & Chen, H. (2023) · Integrative Medicine in Nephrology and Andrology · doi:10.1097/imna-d-22-00018 · Cited by 3

Cardiovascular Complications of COVID-19: Review of Cardiac Injury Pathophysiology and Clinical Evidence

Rasputniak, O. V., Гавриленко, Т. И., Pidgaina, O. A., Trembovetska, O. M., Lomakovskyi, O. M., & Shnaider, L. M. (2024) · Ukrainian journal of cardiovascular surgery · doi:10.30702/ujcvs/24.32(02)/rg021-92104 · Cited by 2

Early pulmonary fibrosis-like changes between delta and pre-delta periods in patients with severe COVID-19 pneumonia on mechanical ventilation

Yoo, J.-W., Kim, W.-Y., Chung, C., Cho, Y.-J., Lee, J., Jegal, Y., Kim, J., Joh, J., Park, T., Baek, A., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-77405-7 · Cited by 1

Visceral fat as the main tomographic risk factor for COVID-19 mortality

Hinojosa-Gutiérrez, L. R., González-Sánchez, A. L., Rios-Muñoz, J. A., Aguilar-Guerrero, R., & Macías-Cervantes, H. E. (2024) · Heart & Lung · doi:10.1016/j.hrtlng.2024.12.005 · Cited by 2

HLA Polymorphisms and COVID ‐19 Susceptibility and Severity: Insights From an Iranian Patients Cohort

Hakimi, P., Zaboli, K. A., Golbabapour‐Samakoush, M., Azizimohammadi, S., Soleimani, F., Salmani, M. H., & Teimoori‐Toolabi, L. (2025) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.70570 · Cited by 2

Elevated IL-6, IL-10, and IFN-γ levels in fatal elephant endotheliotropic herpesvirus – hemorrhagic disease cases suggest an excessive proinflammatory cytokine response contributes to pathogenesis

Hoornweg, T. E., Schaftenaar, W., IJzer, J., Mulder, M. M. P., Lugtenburg, M., van Beest, A., de Haan, C. A. M., & Rutten, V. P. M. G. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1645752 · Cited by 2

Revisión bibliográfica: tormenta de citoquinas producida por COVID-19

Jiménez, E. M. F., & Espinoza, C. S. (2022) · Investigación y Desarrollo · doi:10.31243/id.v12.2020.987 · Cited by 2

Derrida, autoimmunity, and critique

Rae, G. (2022) · Distinktion Journal of Social Theory · doi:10.1080/1600910x.2022.2039739 · Cited by 2

Characterization of T Helper 1 and 2 Cytokine Profiles in Newborns of Mothers with COVID-19

Moreira, A. L. E., da Silva, P. A. N., Gomes, R. S., Santos, M. D. O., Ito, C. R. M., Gonçalves, L. C., de Souza, P. P., Peixoto, F. A. D. O., Wastowski, I. J., Carneiro, L. C., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11030910 · Cited by 2

Clinical Outcome in Patients with COVID-19 and Comparison to Serum LDH and D-dimer Levels

Patil, A. R. (2023) · JOURNAL OF COMMUNICABLE DISEASES · doi:10.24321/0019.5138.202303 · Cited by 2

Investigation of Subcarinal Angle and Tracheobronchial Morphology in Patients with COVID 19: A Retrospective Computed Tomography Study

Karabaş, S. A., Çiftçi, R., Ulubaba, H. E., & YOLDAŞ, A. (2023) · Konuralp Tıp Dergisi · doi:10.18521/ktd.1247746 · Cited by 2

Inflammatory predictors (eosinophil, C-RP and IL-6) and effectiveness of oral Azvudine tablets treatment in COVID-19 hospitalized patients: A retrospective, self-controlled study

Zhao, Y., Gao, G., Li, W., Xu, Z., Wang, X., & Chang, R. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e21941 · Cited by 2

A Histological Analysis and Detection of Complement Regulatory Protein CD55 in SARS-CoV-2 Infected Lungs

Silawal, S., Gögele, C., Pelikan, P., Werner, C., Levidou, G., Mahato, R., & Schulze-Tanzil, G. G. (2024) · Life · doi:10.3390/life14091058 · Cited by 2

Diverse effects of clarithromycin and proposal of its clinical application for treating COVID-19 as a repurposing drug

Takemori, N. (2021) · Tropical biomedicine · doi:10.47665/tb.38.3.077 · Cited by 2

Rapid Identification of Druggable Targets and the Power of the PHENotype SIMulator for Effective Drug Repurposing in COVID-19Preprint

Maria, N. I., Rapicavoli, R. V., Alaimo, S., Bischof, E. Y., Stasuzzo, A., Broek, J. A. C., Pulvirenti, A., Mishra, B., Duits, A. J., & Ferro, A. (2021) · Research Square · doi:10.21203/rs.3.rs-287183/v1 · Cited by 2

Editorial: Chronic Inflammation and Related Diseases: From Mechanisms to Therapies

Kang, S.-Y., & Ryu, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310460 · Cited by 2

Tailoring combinational therapy with Monte Carlo method-based regression modeling

Wang, B., Yuan, S., Chan, C. C.-Y., Tsang, J. O., He, Y., Yuen, K., Ding, X., & Chan, J. F. (2023) · Fundamental Research · doi:10.1016/j.fmre.2023.03.008 · Cited by 1

Pathophysiology And Clinical Manifestation of Cytokine Storm

Khudhair, A. Y., Zwamel, A. H., Munshid, M. C., & Al-fahham, A. A. (2024) · INTERNATIONAL JOURNAL OF HEALTH & MEDICAL RESEARCH · doi:10.58806/ijhmr.2024.v3i12n05 · Cited by 1

Cytokine Storm in COVID-19—Immunopathological Mechanisms, Clinical Considerations, and Therapeutic Approaches: The REPROGRAM Consortium Position Paper

Bhaskar, S. M. M., Sinha, A., Banach, M., Mittoo, S., Weissert, R., Kass, J. S., Rajagopal, S., Pai, A. R., & Kutty, S. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01648 · Cited by 524

Cytokine Storm in Pathogenesis of COVID-19 Complications

Rasputniak, O. V., Гавриленко, Т. И., Pidgaina, O. A., Shnaider, L. M., Lomakovskyi, O. M., & Kalashnikov, S. A. (2024) · Ukrainian journal of cardiovascular surgery · doi:10.30702/ujcvs/24.32(03)/rg042-7384

On the Alert for Cytokine Storm: Immunopathology in COVID ‐19

Henderson, L. A., Canna, S., Schulert, G. S., Volpi, S., Lee, P. Y., Kernan, K. F., Caricchio, R., Mahmud, S. A., Hazen, M. M., Halyabar, O., et al. (2020) · Arthritis & Rheumatology · doi:10.1002/art.41285 · Cited by 651

Cytokine Storm: A Substantial Peril to Human Health

(2020) · International Journal of Pharmaceutical Research · doi:10.31838/ijpr/2021.13.01.312 · Cited by 1